Overview

Atomoxetine in the Treatment of Binge Eating Disorder

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to assess the efficacy and safety of atomoxetine compared with placebo in outpatients with binge eating disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Lindner Center of HOPE
Collaborator:
University of Cincinnati
Treatments:
Atomoxetine Hydrochloride